Focused Wealth Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Focused Wealth Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-800	Closed	-$51K	–	902
2020 Q2	$51K	Sell	800 -375	-32%	-$25.7K	0.01%	305
2020 Q1	$60K	Sell	1,175 -10	-0.8%	-$670	0.02%	268
2019 Q4	$94K	Sell	1,185 -2,255	-66%	-$134K	0.02%	259
2019 Q3	$167K	Buy	3,440 +300	+10%	+$15.6K	0.05%	160
2019 Q2	$165K	Hold	3,140	–	–	0.04%	166
2019 Q1	$166K	Hold	3,140	–	–	0.05%	150
2018 Q4	$129K	Buy	3,140 +400	+15%	+$15K	0.04%	191
2018 Q3	$104K	Buy	+2,740	New	+$121K	0.04%	226
2018 Q1	–	Sell	-6,400	Closed	-$252K	–	758
2017 Q4	$252K	Buy	+6,400	New	+$239K	0.08%	123

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Focused Wealth Management's GBT Position: Q3 2020 in Review

Focused Wealth Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 800 shares — an estimated $51K sold.

Focused Wealth Management first reported a position in GBT in Q4 2017 and held it in 9 quarters. The position peaked at $252K in Q4 2017. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

Focused Wealth Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Focused Wealth Management sold 800 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $51K.
Focused Wealth Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 9 quarters.
Focused Wealth Management's Global Blood Therapeutics, Inc. position peaked at $252K in Q4 2017.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Focused Wealth Management's 13F filing for Q3 2020, filed 19 Oct 2020.